ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Bloomage Biotechnology (688363.SHG)
Bloomage Biotechnology stock price today, ATLAS forecast and fair value
Basic Materials · Specialty Chemicals · Shanghai Stock Exchange · China
CN¥34.43▼ -3.29%
Prices as of Oct 27, 2026 · CNY
Chance of rising in 1 month
51%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Bloomage Biotechnology in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Bloomage Biotechnology
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Bloomage Biotechnology a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CN¥32.77 and CN¥36.33; in 9 out of 10, between CN¥29.90 and CN¥39.81. Estimated annual volatility is 26%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- CN¥16.0B
- Market cap (USD)
- $2.4B
- P/E ratio
- 73.6
- Dividend yield
- 0.54%
- 52-week high
- CN¥55.15
- 52-week low
- CN¥32.92
- Revenue (12 months)
- CN¥3.7B
- Gross margin
- 66.7%
- Operating margin
- 3.0%
- Net margin
- 6.1%
- Beta
- 0.45
What this means
ATLAS does not publish a fair value for 688363.SHG right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks 688363.SHG has traded between CN¥32.92 and CN¥55.15. Today it is 37.6% below that high and 5% above its low.
On the business: net margin is 6.1%; it trades at 73.6 times earnings.
Its beta is 0.45: it tends to move less than the market.
About the company
Bloomage BioTechnology Corporation Limited develops, produces, and sells bioactive materials.
Want to see everything about Bloomage Biotechnology?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Bloomage Biotechnology do?
Bloomage BioTechnology Corporation Limited develops, produces, and sells bioactive materials.
What is the chance 688363.SHG goes up next month?
51%: close to a coin flip. In half of the simulated outcomes, 688363.SHG ends the month between CN¥32.77 and CN¥36.33.
How big is Bloomage Biotechnology and what is its P/E ratio?
Bloomage Biotechnology's market capitalization is CN¥16.0B. Its price-to-earnings (P/E) ratio is 73.6: you pay CN¥73.6 for each CN¥1.00 of yearly earnings.
Does Bloomage Biotechnology pay a dividend?
Yes. 688363.SHG's current dividend yield is 0.54% at today's price (CN¥34.43).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer